查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1587830

被忽视的热带疾病治疗市场规模、份额、趋势分析报告：按疾病、产品、地区和细分市场预测，2024-2030 年

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Disease (Dengue, Rabies, Trachoma, Chagas Disease), By Product (Drugs, Vaccines), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

被忽视的热带疾病治疗市场的成长和趋势

Grand View Research, Inc.最新报告显示，到2030年，全球被忽视的热带疾病治疗市场规模预计将达到52.5亿美元，预测期内复合年增长率为4.8%。

被忽视的热带疾病的日益流行被认为是造成影响的关键驱动因素。

根据世界卫生组织2018年发表的资料，冈比亚结核病在中非和西非24个国家流行。大约 98% 的昏睡病报告病例都是由这种原因引起的。此外，据 CDC 称，登革热每年感染约 400 人。

此外，根据世界卫生组织2019年发布的统计数据，超过15亿人，即世界人口的24%，感染了土源性蠕虫病。这些感染疾病广泛分布于热带和亚热带地区，主要发生在美洲、撒哈拉以南非洲、东亚和中国。

正在研发的疫苗和药物也被认为是预测期内推动市场成长的关键因素之一。例如，拜耳公司正在开发硝呋替莫（BAYA2502），目前正处于治疗南美锥虫病的 III 期临床试验中。此外，强生服务公司正在开发一种200毫克贝达奎林单药治疗方案，用于治疗痲疯病的II期临床试验，预计将于2021年完成。

此外，Instituto Butantan 和默克公司于 2018 年合作开发了一种针对登革热的疫苗。 Instituto Butantan 正在巴西开发登革热候选疫苗 TV003，目前正在进行第 3 期临床试验。默克公司 (Merck & Co., Inc.) 列出了 Instituto Butantan 的发展基金。

F. Hoffmann-La Roche Ltd、Bayer AG、GlaxoSmithKline plc、Novartis AG、Pfizer, Inc.、Eisai Co. Ltd.、Sanofi、Astellas Pharma、Takeda Pharmaceutical Company Limited、Gilead Sciences 将推动整体市场成长这些公司参与新产品市场开拓被认为是热带疾病治疗市场的成长要素。

热带疾病治疗市场报告亮点

  • 由于发病率不断上升，登革热在 2023 年占据了最大的细分市场。
  • 由于人们对该疾病的认识不断增强，预计布鲁里溃疡将成为预测期内成长最快的部分。
  • 到2023年，药品预计将成为最大的产品领域。
  • 由于研发线产品的强劲存在，疫苗预计将成为预测期内成长最快的部分。
  • 2023 年，亚太地区将主导被忽视的热带疾病治疗市场。
  • 预计拉丁美洲将在预测期内经历最快的成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章被忽视的热带疾病治疗市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 被忽视的热带疾病治疗市场分析工具
    • 波特的分析
    • PESTEL分析

第四章被忽视的热带疾病治疗市场：按产品估计和趋势分析

  • 细分仪表板
  • 被忽视的热带疾病治疗市场：产品变化分析，百万美元，2023 年和 2030 年
  • 药品
    • 寄生虫控制
    • 抗真菌剂
    • 抗生素
    • 其他的
  • 疫苗

第五章被忽视的热带疾病治疗市场：按疾病分类的估计和趋势分析

  • 细分仪表板
  • 被忽视的热带疾病治疗市场：疾病变化分析，百万美元，2023 年和 2030 年
  • 登革热
  • 狂犬病
  • 沙眼
  • 布鲁里溃疡
  • 草莓瘤
  • 麻风
  • 南美锥虫病
  • 人类非洲锥虫病
  • 利什曼原虫症

第六章被忽视的热带疾病治疗市场：区域估计和趋势分析

  • 2023 年和 2030 年被忽视的热带疾病治疗市场占有率（按地区划分），百万美元。
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 南非
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • Bayer AG
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer, Inc
    • Eisai Co. Ltd.
    • Sanofi.
    • Astellas Pharma
    • Takeda Pharmaceutical Company Limited
    • Gilead Sciences
Product Code: GVR-3-68038-787-2

Neglected Tropical Disease Treatment Market Growth & Trends:

The global neglected tropical disease treatment market size is expected to reach USD 5.25 billion by 2030, expanding at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of neglected tropical diseases is considered to be the vital impact rendering driver.

According to the data published in the WHO in 2018, T.B. Gambiense is endemic in 24 countries of Central and West Africa. This caused around 98% of reported cases of sleeping sickness. Furthermore, according to the CDC, around 400 people are infected annually by dengue.

Moreover, according to the statistics published in the WHO in 2019, more than 1.5 billion or 24% of the world's population are infected with soil-transmitted helminthiases. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China.

Presence of pipeline vaccines and drugs is also considered to be one of the major factors driving the market growth over the forecast period. For instance, Bayer AG is developing Nifurtimox (BAYA2502), currently under phase III clinical trials for the treatment of Chagas disease. Furthermore, Johnson & Johnson Services Inc. is developing Bedaquiline 200mg monotherapy regimen which is under phase II clinical trials for the treatment of leprosy and the study is estimated to be completed in 2021.

In addition, Instituto Butantan and Merck & Co., Inc. collaborated to develop vaccines against dengue in 2018. The Instituto Butantan is developing a dengue vaccine candidate in Brazil, TV003, which is in an ongoing Phase III clinical trial. Merck & Co., Inc. will provide funds to Instituto Butantan for its development.

Presence of key players such as F. Hoffmann-La Roche Ltd, Bayer AG, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Eisai Co. Ltd., Sanofi, Astellas Pharma, Takeda Pharmaceutical Company Limited, and Gilead Sciences is expected to fuel to the overall market growth. Involvement of these players in new product development is considered to be the contributing factor for the NTD treatment market.

Tropical Disease Treatment Market Report Highlights:

  • Dengue held the largest segment share in 2023 owing to its increasing prevalence rate
  • Buruli ulcer is estimated to be the fastest growing segment over the forecast period owing to rising awareness about the disease
  • In 2023, drugs were anticipated to be the largest product segment
  • Vaccines are estimated to be the fastest growing segment over the forecast period due to strong presence of pipeline products
  • Asia Pacific dominated the neglected tropical disease treatment market in 2023
  • Latin America is estimated to witness the fastest growth over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neglected Tropical Disease Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neglected Tropical Disease Treatment Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neglected Tropical Disease Treatment Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Drugs
    • 4.3.1. Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Anti-Parasite
      • 4.3.2.1. Anti-Parasite Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Antifungal
      • 4.3.3.1. Antifungal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Antibiotics
      • 4.3.4.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Vaccines
    • 4.4.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neglected Tropical Disease Treatment Market: Disease Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neglected Tropical Disease Treatment Market: Disease Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Dengue
    • 5.3.1. Dengue Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Rabies
    • 5.4.1. Rabies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Trachoma
    • 5.5.1. Trachoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Buruli Ulcer
    • 5.6.1. Buruli Ulcer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Yaws
    • 5.7.1. Yaws Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Leprosy
    • 5.8.1. Leprosy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Chagas Disease
    • 5.9.1. Chagas Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Human African Trypanosomiasis
    • 5.10.1. Human African Trypanosomiasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Leishmaniases
    • 5.11.1. Leishmaniases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Neglected Tropical Disease Treatment Market Share, By Region, 2023 & 2030, USD Million.
  • 6.2. North America
    • 6.2.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. UAE
      • 6.6.2.1. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. F. Hoffmann-La Roche Ltd
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Bayer AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. GlaxoSmithKline plc
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Novartis AG
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Pfizer, Inc
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Eisai Co. Ltd.,
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Sanofi.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Astellas Pharma
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Takeda Pharmaceutical Company Limited
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Gilead Sciences
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • TABLE 1 List of Abbreviation
  • TABLE 2 North America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 3 North America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 4 U.S. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 5 U.S. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 6 Canada Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 7 Canada Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 8 Europe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 9 Europe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 10 U.K. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 11 U.K. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 12 Germany Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 13 Germany Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 14 Asia Pacific Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 15 Asia Pacific Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 16 Japan Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 17 Japan Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 18 China Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 19 China Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 20 India Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 21 India Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 22 Indonesia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 23 Indonesia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 24 Singapore Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 25 Singapore Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 26 Philippines Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 27 Philippines Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 28 Latin America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 29 Latin America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 30 Mexico Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 31 Mexico Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 32 Brazil Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 33 Brazil Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 34 Argentina Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 35 Argentina Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 36 Colombia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 37 Colombia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 38 Bolivia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 39 Bolivia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 40 MEA Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 41 MEA Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 42 South Africa Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 43 South Africa Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 44 Saudi Arabia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 45 Saudi Arabia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 46 UAE Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 47 UAE Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 48 Nigeria Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 49 Nigeria Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 50 Ghana Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 51 Ghana Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 52 Zimbabwe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 53 Zimbabwe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global Neglected Tropical Disease Treatment market- Key market driver analysis
  • FIG. 7 Global Neglected Tropical Disease Treatment market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global Neglected Tropical Disease Treatment market - Porter's analysis
  • FIG. 10 Global Neglected Tropical Disease Treatment market - PESTEL analysis
  • FIG. 11 Global Neglected Tropical Disease Treatment market disease outlook key takeaways
  • FIG. 12 Global Neglected Tropical Disease Treatment market: Disease movement analysis
  • FIG. 13 Dengue market estimates, 2018 - 2030 (USD Million)
  • FIG. 14 Rabies market estimates, 2018 - 2030 (USD Million)
  • FIG. 15 Trachoma market estimates, 2018 - 2030 (USD Million)
  • FIG. 16 Buruli ulcer market estimates, 2018 - 2030 (USD Million)
  • FIG. 17 Yaw's market estimates, 2018 - 2030 (USD Million)
  • FIG. 18 Leprosy market estimates, 2018 - 2030 (USD Million)
  • FIG. 19 Chagas disease market estimates, 2018 - 2030 (USD Million)
  • FIG. 20 Human African trypanosomiasis (sleeping sickness) market estimates, 2018 - 2030 (USD Million)
  • FIG. 21 Leishmaniases market estimates, 2018 - 2030 (USD Million)
  • FIG. 22 Soil-transmitted helminthiases market estimates, 2018 - 2030 (USD Million)
  • FIG. 23 Others market estimates, 2018 - 2030 (USD Million)
  • FIG. 24 Global Neglected Tropical Disease Treatment market Product type outlook key takeaways
  • FIG. 25 Global Neglected Tropical Disease Treatment market: Product type movement analysis
  • FIG. 26 Drugs market estimates, 2018 - 2030 (USD Million)
  • FIG. 27 Vaccines market estimates, 2018 - 2030 (USD Million)
  • FIG. 28 Regional marketplace: Key takeaways
  • FIG. 29 Global Neglected Tropical Disease Treatment market: Regional movement analysis
  • FIG. 30 North America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 31 U.S. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 32 Canada Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 33 Europe Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 34 U.K. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 35 Germany Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 36 Asia Pacific Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 37 Japan Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 38 China Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 39 India Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 40 Indonesia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 41 Singapore Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 42 Philippines Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 43 Latin America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG 44 Brazil Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 45 Mexico Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 46 Argentina Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 47 Colombia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 48 Bolivia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million
  • FIG. 49 MEA Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 50 South Africa Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 51 Saudi Arabia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 52 UAE market, 2018 - 2030 (USD Million)
  • FIG. 53 Nigeria market, 2018 - 2030 (USD Million)
  • FIG. 54 Ghana market, 2018 - 2030 (USD Million)
  • FIG. 55 Zimbabwe market, 2018 - 2030 (USD Million)
  • FIG. 56 Strategy framework